During the past decade, Crescent Care conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Crescent Care" #1 sponsor was "AIDS Malignancy Consortium" with 1 trials, followed by "Bowen Chung, MD, MSHS" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "RTI International" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Crescent Care" #1 collaborator was "University of California, San Francisco" with 2 trials as a collaborator, "Arming Minorities Against Addiction & Disease" with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "Healthy African American Families II" with 1 trials as a collaborator and "Louisiana Community Health Outreach Network" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Crescent Care" are "Anal Cancer" (1 trials), "Depressive Symptoms" (1 trials), "Gonorrhoea" (1 trials), "HIV Infection" (1 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "Crescent Care" in a lesser frequency.

Most popular intervention types in "Crescent Care" are "Drug" (4 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZD0914" (1 trials), "B/F/TAF" (1 trials), "Ceftriaxone" (1 trials), "MTZ 2 g" (1 trials) and "MTZ 500 mg twice daily x 7 days" (1 trials). Other intervention names were less common.

The vast majority of trials in "Crescent Care" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Crescent Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Crescent Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Crescent Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".